Botulinum toxin as a biological weapon: Medical and public health management

JAMA

Volumn 285, Issue 8, 2001, Pages 1059-1070

  Arnon, Stephen S ^a   Schechter, Robert ^a   Inglesby, Thomas V ^c   Henderson, Donald A ^d   Bartlett, John G ^c   Ascher, Michael S ^b   Eitzen, Edward ^e   Fine, Anne D ^f   Hauer, Jerome ^g   Layton, Marcelle ^f   Lillibridge, Scott ^h   Osterholm, Michael T ⁱ   O'Toole, Tara ^d   Parker, Gerald ^e   Perl, Trish M ^c   Russell, Philip K ^d   Swerdlow, David L ^h   Tonat, Kevin ^j  

^a Infant Botulism Treatment and Prevention Program   (United States)

^b VIRAL AND RICKETTSIAL DISEASE LABORATORY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Public Health   (United States)

^e UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^f NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^g SCIENCE APPLICATIONS INTERNATIONAL CORPORATION   (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

ⁱ Infection Control Advisory Network Inc   (United States)

^j U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN;

AEROSOL; ARTICLE; BACTERIAL VIRULENCE; BIOLOGICAL WARFARE; CLINICAL FEATURE; CLOSTRIDIUM BOTULINUM; DIFFERENTIAL DIAGNOSIS; EMERGENCY; EPIDEMIC; HUMAN; INFECTION CONTROL; LABORATORY TEST; MEDICAL INFORMATION; PRIORITY JOURNAL;

EID: 0035961566     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.285.8.1059     Document Type: Article

References (106)

1. Anthrax as a biological weapon: Medical and public health management
2. Smallpox as a biological weapon: Medical and public health management
3. Plague as a biological weapon: Medical and public health management
4. Biological and chemical terrorism: Strategic plan for preparedness and response: Recommendations of the CDC Strategic Planning Workgroup
5. Clinical recognition and management of patients exposed to biological warfare agents
6. Bacterial toxins: A table of lethal amounts
7. Clostridial neurotoxins: The molecular pathogenesis of tetanus and botulism
8. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery
9. Properties and use of botulinum toxin and other microbial neurotoxins in medicine
10. Botulinum toxin type A as a migraine preventive treatment
11. Botulinum toxin A and mechanical low back pain
12. How Japan germ terror alerted world
13. History of chemical and biological warfare: An American perspective
14. Botulism
15. Botulism from inhalation
16. At bleak Asian site, killer germs survive
17. Iraq's biological weapons: The past as future?
18. The covert use of chemical and biological warfare against United States strategic forces
19. Botulism surveillance and emergency response: A public health strategy for a global challenge
20. Clostridium: The sporebearing anaerobes
21. Isolation of an organism resembling Clostridium baratii which produces type F botulinal toxin from an infant with botulism
22. Two cases of type E infant botulism caused by neurotoxigenic Clostridium butyricum in Italy
23. Botulism as an intestinal toxemia
24. Crystal structure of botulinum neurotoxin type A and implications for toxicity
25. Efficacy of prophylactic and therapeutic administration of antitoxin for inhalation botulism
26. Experimental botulism in monkeys: A clinical pathological study
27. Systemic toxicity of botulinum toxin by intramuscular injection in the monkey
28. Wound botulism in a patient with a tooth abscess: Case report and literature review
29. Clinical features of types A and B foodborne botulism
30. Motor nerve growth induced by botulinum toxin as a regenerative phenomenon
31. Patient recovery from type A botulism: Morbidity assessment following a large outbreak
32. Botulism in the United States: A clinical and epidemiologic review
33. Botulinum toxins
34. Botulism in the United States, 1899-1969
35. Epidemiology of human foodborne botulism
36. Destruction of botulinum toxin in food and water
37. Biological warfare agents as threats to potable water
38. Stability of botulin toxins in solutions and beverages
39. Type B botulism in man
40. Botulism type B: Epidemiological aspects of an extensive outbreak
41. A large outbreak of botulism: The hazardous baked potato
42. The changing epidemiology of adult botulism in the United States
43. Laboratory diagnosis in a large outbreak of type A botulism: Confirmation of the value of coproexamination
44. Restaurant-associated type A botulism: Transmission by potato salad
45. Type A botulism from sauteed onions: Clinical and epidemiological observations
46. Botulism from chopped garlic: Delayed recognition of a majot outbreak
47. An outbreak of type A botulism associated with a commercial cheese sauce
48. An international outbreak of type E botulism due to uneviscerated fish
49. An outbreak of foodborne botulism associated with contaminated hazelnut yoghurt
50. Foodborne botulism in Italy
51. An outbreak of type A foodborne botulism in Taiwan due to commercially preserved peanuts
52. Clostridium botulinum type F: Isolation from venison jerky
53. Type F botulism due to neurotoxigenic Clostridium baratii from an unknown source in an adult
54. Susceptibility of monkeys, goats and small animals to oral administration of botulinum toxin types B, C and D
55. Clostridium botulinum type F with recent observations on other types
56. An outbreak of type C botulism in captive monkeys
57. Another type of Clostridium botulinum
58. Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States, 1975-1988
59. American Association of Electrodiagnostic Medicine case report 16: Botulism
60. Clinical spectrum of botulism
61. A six-year-old gift with tick paralysis
62. Equine antitoxin use and other factors that predict outcome in type A foodborne botulism
63. Infant botulism
64. 2 heptavalent botulism immune globulin of equine origin during an outbreak of type E botulism in Egypt
65. Hypersensitivity reactions associated with botulinal antitoxin
66. Infant botulism: A review of 12 years' experience at the Children's Hospital of Philadelphia
67. Public-health preparedness for biological terrorism in the USA
68. Potentiation of Clostridium botulinum toxin by aminoglycoside antibiotics: Clinical and laboratory observations
69. Clindamycin and nicotinic neuromuscular transmission
70. Wound botulism in pediatrics
71. Botulism in a pregnant woman
72. Observations of an infant born to a mother with botulism
73. Clinical trial of human botulism immune globulin
74. Human immune response to botulinum pentavalent (ABCDE) toxoid determined by a neutralization test and by an enzyme-linked immunosorbent assay
75. Development of vaccines for prevention of botulism
76. Strategies for the prevention of a successful biological warfare aerosol attack
77. Detection of type A, B, and E botulism neurotoxin genes in Clostridium botulinum and other Clostridium species by PCR: Evidence of unexpressed type B toxin genes in type A toxigenic organisms
78. Development of an in vitro bioassay for Clostridium botulinum type B neurotoxin in foods that is more sensitive than the mouse bioassay
79. Detection of Clostridium botulinum type A toxin by enzyme-linked immunosorbent assay with antibodies produced in immunologicaliy tolerant animals
80. Half-life of the maternal IgG1 allotype in infants
81. Phage libraries for generation of anti-botulinum scFv antibodies
82. Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs
83. Identifying the principal protective antigenic determinants of type A botulinum neurotoxin
84. Phage libraries: A new route to clinically useful antibodies